ATE359811T1 - Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe - Google Patents

Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Info

Publication number: ATE359811T1
Authority: AT; Austria
Prior art keywords: vaccines; trehalose; prokaryotic cells; producing prokaryotic; producing
Prior art date: 1999-08-19

Application number

AT00954737T

Other languages

German (de)

English (en)

Inventor

Camilo Anthony Leo Selw Colaco

Original Assignee

Immunobiology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-19

Filing date

2000-08-18

Publication date

2007-05-15

2000-08-18 Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359811T1 publication Critical patent/ATE359811T1/de

Links

229960005486 vaccine Drugs 0.000 title abstract 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 abstract 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 abstract 1
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
210000001236 prokaryotic cell Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT00954737T 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe ATE359811T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9919732.9A GB9919732D0 (en)	1999-08-19	1999-08-19	Trehalose producing cells as vaccines

Publications (1)

Publication Number	Publication Date
ATE359811T1 true ATE359811T1 (de)	2007-05-15

Family

ID=10859499

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00954737T ATE359811T1 (de)	1999-08-19	2000-08-18	Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Country Status (10)

Country	Link
US (1)	US20070243200A1 (fr)
EP (1)	EP1204420B1 (fr)
AT (1)	ATE359811T1 (fr)
AU (1)	AU6709500A (fr)
DE (1)	DE60034460T2 (fr)
DK (1)	DK1204420T3 (fr)
ES (1)	ES2286033T3 (fr)
GB (1)	GB9919732D0 (fr)
PT (1)	PT1204420E (fr)
WO (1)	WO2001013942A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8733289B2 (en) *	2008-04-07	2014-05-27	Rich Products Corporation	Method for preparing edible aquatic animals for storage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5312909A (en) *	1990-03-28	1994-05-17	Gist Brocades, N.V.	Recombinant DNA encoding neutral trehalase
US5422254A (en) *	1992-02-14	1995-06-06	Oy Alko Ab	Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
US6468782B1 (en) *	1996-12-05	2002-10-22	Quadrant Healthcare (Uk) Limited	Methods of preserving prokaryotic cells and compositions obtained thereby

1999
- 1999-08-19 GB GBGB9919732.9A patent/GB9919732D0/en not_active Ceased
2000
- 2000-08-18 AT AT00954737T patent/ATE359811T1/de active
- 2000-08-18 AU AU67095/00A patent/AU6709500A/en not_active Abandoned
- 2000-08-18 DK DK00954737T patent/DK1204420T3/da active
- 2000-08-18 WO PCT/GB2000/003223 patent/WO2001013942A2/fr not_active Ceased
- 2000-08-18 ES ES00954737T patent/ES2286033T3/es not_active Expired - Lifetime
- 2000-08-18 PT PT00954737T patent/PT1204420E/pt unknown
- 2000-08-18 DE DE60034460T patent/DE60034460T2/de not_active Expired - Lifetime
- 2000-08-18 EP EP00954737A patent/EP1204420B1/fr not_active Expired - Lifetime
2007
- 2007-05-29 US US11/807,855 patent/US20070243200A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1204420T3 (da)	2007-09-17
EP1204420A2 (fr)	2002-05-15
DE60034460T2 (de)	2008-01-03
WO2001013942A2 (fr)	2001-03-01
DE60034460D1 (de)	2007-05-31
AU6709500A (en)	2001-03-19
EP1204420B1 (fr)	2007-04-18
PT1204420E (pt)	2007-07-20
ES2286033T3 (es)	2007-12-01
WO2001013942A3 (fr)	2001-09-20
US20070243200A1 (en)	2007-10-18
GB9919732D0 (en)	1999-10-20

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1204420

Country of ref document: EP

Publication	Publication Date	Title
YU19903A (sh)	2006-05-25	Novi receptor nukleinskih kiselina i polipeptida
ATE401097T1 (de)	2008-08-15	Verwendung von imidazochinolinaminen als adjuvantien in dna-impfung
MXPA02006029A (es)	2004-08-23	Lipopeptidos novedosos como agentes antibacterianos.
DE69824013D1 (de)	2004-06-24	Impfstoff gegen hpv
TR200100267T2 (tr)	2001-09-21	İkameli anilid bileşimleri ve yöntemler.
DE69431404D1 (de)	2002-10-24	Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
PT1548032E (pt)	2009-08-13	Péptidos kdr e vacinas que os contêm
BR0315275A (pt)	2005-08-30	Anticorpos que se ligam a receptor de eritropoietina
PT1083903E (pt)	2004-11-30	Indenopirrolocarbazoles em ponte
ATE296094T1 (de)	2005-06-15	Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004017486D1 (de)	2008-12-11	Substituierte heteroarylbenzofuransäuren
IL196900A (en)	2015-03-31	Autologous T cell vaccine compositions
DK1278868T3 (da)	2008-05-19	Muteret form af arginindeiminase
EP1423137A4 (fr)	2005-11-30	Stereo-isomeres de lipopeptide, methodes de preparation afferentes et intermediaires utiles
DE60235836D1 (de)	2010-05-12	Ahren und verwendung davon
TW200508246A (en)	2005-03-01	Anti-dengue virus antibodies, compositions, methods and uses
ATE551069T1 (de)	2012-04-15	Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1290160T3 (da)	2006-07-31	Humane Pellino-polypeptider
DK1234025T3 (da)	2008-11-17	Humane enzymer fra metalloproteasefamilien
BR0313135A (pt)	2005-07-05	Epìtopos de células t em eritropoietina
DE50006526D1 (de)	2004-06-24	Verwendung von anti-idiotypischen antikörpern als impfstoffe gegen krebs
DE69840637D1 (de)	2009-04-16	Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE359811T1 (de)	2007-05-15	Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
ATE476987T1 (de)	2010-08-15	Zusammensetzungen und methoden zur behandlung von candidosen
DE69836759D1 (de)	2007-02-08	Gewebezementproteine aus rhipicephalus appendiculatus